Quipt Home Medical Corp expected to post a loss of 2 cents a share - Earnings Preview

Quipt Home Medical

07/02/2025 21:52

* Quipt Home Medical Corp  QIPT.TO   is expected to show a
fall in
quarterly revenue when it reports  results on February 10 for
the period ending December 31 2024
    * The Wilder Kentucky-based  company is expected to report a
5.3% decrease in revenue to $61.87 million from $65.36 million a
year ago, according to the mean estimate from 3 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Quipt Home Medical Corp
is for
a loss of 2 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Quipt Home
Medical Corp is $7.00​, above​ its last closing price of $2.95.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -0.04       -0.02      -0.04     Missed  -71.5
 Jun. 30 2024  -0.02       -0.01      -0.04     Missed  -166.7
 Mar. 31 2024  0.01        0.01       -0.03     Missed  -549.8
                                                        ​
 Dec. 31 2023  0.01        0.00       -0.01     Missed  -500
 ​​Sep.        0.02        0.00       -0.03     Missed  -850
 30 2023                                                
 Jun. 30 2023  0.00        0.00       -0.03     Missed  -1,696
                                                        .4​
 Mar. 31 2023  0.04        0.04       -0.02     Missed  -147.1
 Dec. 31 2022  0.04        0.05       0.01      Missed  -77.8
 This summary was machine generated February 7 at 21:52 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)